WHO ICTRP trial
Effect and mechanism of probiotics in adjuvant treatment of reflux esophagitis
ChiCTR2200059624 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200059624 |
|---|---|
| Public title | Effect and mechanism of probiotics in adjuvant treatment of reflux esophagitis |
| Scientific title | Effect and mechanism of probiotics in adjuvant treatment of reflux esophagitis |
| Primary sponsor | The First Hospital of Nanchang |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | reflux esophagitis |
| Interventions | Case group:Oral probiotics;Case group2:Oral placebo;Healthy control group:Nothing |
| Registration date | May 4, 2022 |
| Target size | Case group:40;Case group2:40;Healthy control group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: